| Financial Year |
March 31 2023 |
| Monetary Funds |
2,276,666,603.39 |
| Held-for-trading Financial Assets |
2,260,000.00 |
| Notes Receivable |
79,930,614.71 |
| Accounts Receivable |
1,868,318,656.88 |
| Advances to Suppliers |
88,169,078.69 |
| Other Receivables |
89,198,998.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
394,609,469.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,485,552.70 |
| Total Current Assets |
6,591,320,263.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
211,242,095.42 |
| Investment Properties |
24,264,142.98 |
| Fixed Assetes |
445,332,715.32 |
| Under-construction Projects |
99,150,765.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,896,218.96 |
| R&D expenses |
-- |
| Goodwill |
1,336,046,005.04 |
| Long-Term Deferred and Prepaid Expenses |
30,681,802.33 |
| Deferred Income Tax Assets |
93,828,701.62 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,979,752,595.97 |
| Total Assets |
9,571,072,859.54 |
| Short-Term Loans |
326,492,903.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,807,906.30 |
| Accounts Payable |
728,850,179.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
191,026,340.92 |
| Taxes Payable |
66,180,325.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
78,012,776.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,023,001.72 |
| Other Current Liabilities |
64,378,085.00 |
| Sub-Total of Current Liabilities |
1,686,216,935.46 |
| Long-term Loans |
267,078,903.75 |
| Bonds Payable |
321,291,342.10 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
14,088,038.39 |
| Deferred Income Tax Liabilities |
12,345,602.72 |
| Other Non-Current Liabilities |
4,114,939.89 |
| Sub-Total of Non-Current Liabilities |
722,425,378.57 |
| Total Liabilities |
2,408,642,314.03 |
| Paid-In Capital(Or Share Stock) |
1,074,370,875.00 |
| Capital Surplus |
2,867,203,390.14 |
| Surplus Reserve |
256,551,815.12 |
| LESS:Treasury Stock |
160,153,414.85 |
| Undistributed Profits |
3,126,205,566.29 |
| Minority Stockholder's Interest |
97,190,524.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,065,240,020.69 |
| Owner's Equity（Stockholder's Equity） |
7,162,430,545.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,571,072,859.54 |
